SEC Filings

PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 02/19/2019
Entire Document


27 Managed Care Status • Available as a prescription option to 204M covered lives • Broad coverage by a majority of managed care providers • Express Scripts (ESI) lifted their exclusion of Zohydro ® ER with BeadTek ® in Jan. 2016 • In 2015, MedImpact and UnitedHealthcare removed Zohydro ® ER with BeadTek ® from the NDC block Source: MMIT as of July 2018 (managed care chart). (1) Custom plans may vary. Formulary Status Zohydro ER Top National Payers Commercial Formulary Status (1) Express Scripts T3 CVS Health Caremark T3 OptumRx/United HealthCare Optum 0 T3; United 0 T3 w/ST Aetna/Coventry T3-2ST Prime Therapeutics T3; Net Results F - NC (40% Lives) MedImpact T3 WellPoint/Anthem T3-2ST CIGNA T3-2ST Kaiser Foundation Health Plans NC EnvisionRX T2 Preferred , 7% Preferred (PA/ST) , 1% Covered , 35% Covered (PA/ST) , 34% Not Covered , 21% Not Listed , 3% Managed Care Status